For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...
The medication is not a replacement for CPAP therapy, which remains the first-line treatment for OSA. “This is the first drug treatment for obstructive sleep apnea, and so that’s exciting ...
for the first-line treatment of unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G/GEJ) in adults whose tumors express PD-L1 (≥1). "Today’s FDA ...
The FDA approved tislelizumab plus chemotherapy for the first-line treatment of unresectable or metastatic gastric or GEJ adenocarcinoma. The FDA has approved tislelizumab-jsgr (Tevimbra) for use with ...
Developing the Theory of Relativity did not take Einstein a single "forward-pass" where he came up with the theory with the first 1000 words ... where the line of progress increases so fast ...
Wendy Williams Admits Being on TV 'Was About the Money' and Now Only Has $15 in Treatment Facility: 'This Is My Life' ...
As the first ... social anxiety disorders and understanding stress resilience. Looking ahead, Professor Neumann's research raises intriguing questions about the future of psychiatric treatment ...
US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans. "This is a major step ...
Thousands of selfie-taking Ho Chi Minh City residents crammed into train carriages Sunday as the traffic-clogged business hub celebrated the opening of its first-ever metro line after years of delays.
When serotonin levels are low, people may experience symptoms of anxiety and depression. SSRIs are considered first-line treatment for SAD because of their efficacy and mild side effect profile, which ...
If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...
usable even in first-line treatment, the encorafenib regimen has demonstrated high response rates that are rapid and durable. This represents an encouraging sign of continued disease control and a ...